CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Open-market sale Chief Executive Officer sold 15,000 shares at an average $65.25 ($978,683)
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale CBO & COO sold 25,000 shares at an average $60.40 ($1,509,971)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- D/A Other Amended Notice of Exempt Offering of Securities
- D Other Notice of Sales of Unregistered Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 1,563 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 794 shares (to pay taxes)
Page 26 of 45 · 883 filings